Literature DB >> 28866383

Renal glucose metabolism in normal physiological conditions and in diabetes.

Mazen Alsahli1, John E Gerich2.   

Abstract

The kidney plays an important role in glucose homeostasis via gluconeogenesis, glucose utilization, and glucose reabsorption from the renal glomerular filtrate. After an overnight fast, 20-25% of glucose released into the circulation originates from the kidneys through gluconeogenesis. In this post-absorptive state, the kidneys utilize about 10% of all glucose utilized by the body. After glucose ingestion, renal gluconeogenesis increases and accounts for approximately 60% of endogenous glucose release in the postprandial period. Each day, the kidneys filter approximately 180g of glucose and virtually all of this is reabsorbed into the circulation. Hormones (most importantly insulin and catecholamines), substrates, enzymes, and glucose transporters are some of the various factors influencing the kidney's role. Patients with type 2 diabetes have an increased renal glucose uptake and release in the fasting and the post-prandial states. Additionally, glucosuria in these patients does not occur at plasma glucose levels that would normally produce glucosuria in healthy individuals. The major abnormality of renal glucose metabolism in type 1 diabetes appears to be impaired renal glucose release during hypoglycemia.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Glucose homeostasis; Glucose metabolism; Glucose physiology; Glucose transporters; Renal glucose metabolism; SGLT2; Sodium-glucose co-transporter 2

Mesh:

Substances:

Year:  2017        PMID: 28866383     DOI: 10.1016/j.diabres.2017.07.033

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  29 in total

1.  Impaired glucose tolerance, glucagon, and insulin responses in mice lacking the loop diuretic-sensitive Nkcc2a transporter.

Authors:  Lisa Kelly; Mohammed M Almutairi; Shams Kursan; Romario Pacheco; Eduardo Dias-Junior; Hayo Castrop; Mauricio Di Fulvio
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

2.  Species-specific low plasma glucose in fish is associated with relatively high tissue glucose content and is inversely correlated with cardiac glycogen content.

Authors:  Connie E Short; William R Driedzic
Journal:  J Comp Physiol B       Date:  2018-07-14       Impact factor: 2.200

Review 3.  Why does obesity cause diabetes?

Authors:  Samuel Klein; Amalia Gastaldelli; Hannele Yki-Järvinen; Philipp E Scherer
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

4.  Sorafenib decreases glycemia by impairing hepatic glucose metabolism.

Authors:  Jingjing Ma; Fang Sui; Yan Liu; Mengmeng Yuan; Hui Dang; Rui Liu; Bingyin Shi; Peng Hou
Journal:  Endocrine       Date:  2022-10-07       Impact factor: 3.925

5.  Hungry for your alanine: when liver depends on muscle proteolysis.

Authors:  Theresia Sarabhai; Michael Roden
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 6.  Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Life (Basel)       Date:  2021-04-25

7.  Proximal tubular epithelial insulin receptor mediates high-fat diet-induced kidney injury.

Authors:  Hak Joo Lee; Meenalakshmi M Mariappan; Luke Norton; Terry Bakewell; Denis Feliers; Sae Byeol Oh; Andrew Donati; Cherubina S Rubannelsonkumar; Manjeri A Venkatachalam; Stephen E Harris; Isabelle Rubera; Michel Tauc; Goutam Ghosh Choudhury; C Ronald Kahn; Kumar Sharma; Ralph A DeFronzo; Balakuntalam S Kasinath
Journal:  JCI Insight       Date:  2021-02-08

Review 8.  Implications of Aquaglyceroporin 7 in Energy Metabolism.

Authors:  Francesco Maria Iena; Janne Lebeck
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

9.  Metabolic reprogramming involving glycolysis in the hibernating brown bear skeletal muscle.

Authors:  Blandine Chazarin; Kenneth B Storey; Anna Ziemianin; Stéphanie Chanon; Marine Plumel; Isabelle Chery; Christine Durand; Alina L Evans; Jon M Arnemo; Andreas Zedrosser; Jon E Swenson; Guillemette Gauquelin-Koch; Chantal Simon; Stephane Blanc; Etienne Lefai; Fabrice Bertile
Journal:  Front Zool       Date:  2019-05-06       Impact factor: 3.172

10.  Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.

Authors:  Zydrune Polianskyte-Prause; Tuomas A Tolvanen; Sonja Lindfors; Vincent Dumont; Mervi Van; Hong Wang; Surjya N Dash; Mika Berg; Jette-Britt Naams; Laura C Hautala; Harry Nisen; Tuomas Mirtti; Per-Henrik Groop; Kristiina Wähälä; Jukka Tienari; Sanna Lehtonen
Journal:  FASEB J       Date:  2018-10-15       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.